Genetic diversity in Plasmodium falciparum merozoite surface protein 1 and 2 coding genes and its implications in malaria epidemiology: A review of published studies from 1997-2007

Journal of Vector Borne Diseases

Volumn 46, Issue 1, 2009, Pages 1-12

  Kiwanuka, Gertrude N ^a  

^a MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

Author keywords

Genetic diversity; Immune response; Merozoite surface protein; Multiplicity; Plasmodium falciparum

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; ERYTHROCYTE MEMBRANE PROTEIN 1; FANSIDAR; HEMOGLOBIN C; HEMOGLOBIN S; MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 2;

ALPHA THALASSEMIA; ANTIMALARIAL DRUG RESISTANCE; DRUG EFFICACY; EPIDEMIC; GENE MUTATION; GENETIC VARIABILITY; HUMAN; MALARIA CONTROL; MALARIA FALCIPARUM; MORBIDITY; NONHUMAN; PARASITE IMMUNITY; PARASITE PREVALENCE; PARASITE TRANSMISSION; PARASITE VIRULENCE; PLASMODIUM FALCIPARUM; PROTOZOAL GENETICS; REVIEW; SICKLE CELL TRAIT; SINGLE NUCLEOTIDE POLYMORPHISM; VACCINATION;

ANIMALS; ANTIGENS, PROTOZOAN; GENETIC VARIATION; HUMANS; MALARIA, FALCIPARUM; MEROZOITE SURFACE PROTEIN 1; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS;

EID: 65349179209     PISSN: 09729062     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Zwetyenga J, Rogier C, Spiegel A, Fontenille D, Trape JF, Mercereau-Puijalon O. A cohort study of Plasmodium falciparum diversity during the dry season in Ndiop, a Senegalese village with seasonal, mesoendemic malaria. Trans R Soc Trop Med Hyg 1999; 93: 375-80.
2. Tami A, Grundmann H, Sutherland C, McBride JS, Cavanagh DR, Campos E, Snounou G, Barnabe C, Tibayrenc M, Warhurst DC. Restricted genetic and antigenic diversity of Plasmodium falciparum under mesoendemic transmission in the Venezuelan Amazon. Parasitology 2002; 124: 569-81.
3. Snounou G, Zhu X, Siripoon N, Jarra W, Thaithong S, Brown KN, Viriyakosol S. Biased distribution of MSP-1 and MSP-2 allelic variants in Plasmodium falciparum populations in Thailand. Trans R Soc Trop Med Hyg 1999; 93: 369-74.
4. Farnert A, Arez AP, Babiker HA, Beck HP, Benito A, Bjorkman A, Bruce MC, Conway DJ, Day KP, Henning L, Mercereau-Puijalon O, Ranford-Cartwright LC, Rubio JM, Snounou G, Walliker D, Zwetyenga J, do Rosario VE. Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study. Trans R Soc Trop Med Hyg 2001; 95: 225-32.
5. Zakeri S, Bereczky S, Naimi P, Pedro Gil J, Djadid ND, Farnert A, Snounou G, Bjorkman A. Multiple genotypes of the merozoite surface proteins 1 and 2 in Plasmodium falciparum infections in a hypoendemic area in Iran. Trop Med Int Health 2005; 10: 1060-4.
6. Basco LK, Tahar R, Escalante A. Molecular epidemiology of malaria in Cameroon. XVIII. Polymorphisms of the Plasmodium falciparum merozoite surface antigen-2 gene in isolates from symptomatic patients. Am J Trop Med Hyg 2004; 70: 238-44.
7. Joshi H, Valecha N, Verma A, Kaul A, Mallick PK, Shalini S, Prajapati SK, Sharma SK, Dev V, Biswas S, Nanda N, Malhotra MS, Subbarao SK, Dash AP. Genetic structure of Plasmodium falciparum field isolates in eastern and north-eastern India. Malar J 2007; 6: 60.
8. Takala SL, Escalante AA, Branch OH, Kariuki S, Biswas S, Chaiyaroj SC, Lal AA. Genetic diversity in the Block 2 region of the merozoite surface protein 1 (MSP-1) of Plasmodium falciparum: additional complexity and selection and convergence in fragment size polymorphism. Infect Genet Evol 2006; 6: 417-24.
9. Ntoumi F, Ngoundou-Landji J, Lekoulou F, Luty A, Deloron P, Ringwald P. Site-based study on polymorphism of Plasmodium falciparum msp-1 and msp-2 genes in isolates from two villages in Central Africa. Parassitologia 2000; 42: 197-203.
10. Ekala MT, Jouin H, Lekoulou F, Mercereau-Puijalon O, Ntoumi F. Allelic family-specific humoral responses to merozoite surface protein 2 (MSP-2) in Gabonese residents with Plasmodium falciparum infections. Clin Exp Immunol 2002; 129: 326-31.
11. Da Silveira LA, Dorta ML, Kimura EA, Katzin AM, Kawamoto F, Tanabe K, Ferreira MU. Allelic diversity and antibody recognition of Plasmodium falciparum merozoite surface protein 1 during hypoendemic malaria transmission in the Brazilian amazon region. Infect Immun 1999; 67: 5906-16.
12. 19) and predominance of the MAD20 allelic type of MSP-1 in Uganda. East Afr Med J 2000; 77: 189-93.
13. Polley SD, Conway DJ, Cavanagh DR, McBride JS, Lowe BS, Williams TN, Mwangi TW, Marsh K. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. Vaccine 2006; 24: 4233-46.
14. Gray JC, Corran PH, Mangia E, Gaunt MW, Li Q, Tetteh KK, Polley SD, Conway DJ, Holder AA, Bacarese-Hamilton T, Riley EM, Crisanti A. Profiling the antibody immune response against blood stage malaria vaccine candidates. Clin Chem 2007; 53: 1244-53.
15. Polley SD, Tetteh KK, Lloyd JM, Akpogheneta OJ, Greenwood BM, Bojang KA, Conway DJ. Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection. J Infect Dis 2007; 195: 279-87.
16. Roussilhon C, Oeuvray C, Muller-Graf C, Tall A, Rogier C, Trape JF, Theisen M, Balde A, Perignon JL, Druilhe P. Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. PLoS Med 2007; 4: e320.
17. Eisen D, Billman-Jacobe H, Marshall VF, Fryauff D, Coppel RL. Temporal variation of the merozoite surface protein-2 gene of Plasmodium falciparum. Infect Immun 1998; 66: 239-46.
18. Felger I, Irion A, Steiger S, Beck HP. Genotypes of merozoite surface protein 2 of Plasmodium falciparum in Tanzania. Trans R Soc Trop Med Hyg 1999; 93 (Suppl 1): 3-9.
19. Tanabe K, Sakihama N, Walliker D, Babiker H, Abdel-Muhsin AM, Bakote'e B, Ohmae H, Arisue N, Horii T, Rooth I, Farnert A, Bjorkman A, Ranford-Cartwright L. Allelic dimorphism-associated restriction of recombination in Plasmodium falciparum MSP-1. Gene 2007; 397: 153-60.
20. Muller DA, Charlwood JD, Felger I, Ferreira C, do Rosario V, Smith T. Prospective risk of morbidity in relation to multiplicity of infection with Plasmodium falciparum in Sao Tome. Acta Trop 2001; 78: 155-62.
21. Mayor A, Saute F, Aponte JJ, Almeda J, Gomez-Olive FX, Dgedge M, Alonso PL. Plasmodium falciparum multiple infections in Mozambique, its relation to other malariological indices and to prospective risk of malaria morbidity. Trop Med Int Health 2003; 8: 3-11.
22. Rubio JM, Berzosa PJ, Benito A. Amplified fragment length polymorphism (AFLP) protocol for genotyping the malarial parasite Plasmodium falciparum. Parasitology 2001; 123: 331-6.
23. Anderson TJ, Haubold B, Williams JT, Estrada-Franco JG, Richardson L, Mollinedo R, Bockarie M, Mokili J, Mharakurwa S, French N, Whitworth J, Velez ID, Brockman AH, Nosten F, Ferreira MU, Day KP. Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. Mol Biol Evol 2000; 17: 1467-82.
24. Zhong D, Afrane Y, Githeko A, Yang Z, Cui L, Menge DM, Temu EA, Yan G. Plasmodium falciparum genetic diversity in western Kenya highlands. Am J Trop Med Hyg 2007; 77: 1043-50.
25. Su XZ, Carucci DJ, Wellems TE. Plasmodium falciparum: parasite typing by using a multicopy microsatellite marker, PfRRM. Exp Parasitol 1998; 89: 262-5.
26. Menegon M, Severini C, Sannella A, Paglia MG, Sangare D, Abdel-Wahab A, Abdel-Muhsin AA, Babiker H, Walliker D, Alano P. Genotyping of Plasmodium falciparum gametocytes by reverse transcriptase polymerase chain reaction. Mol Biochem Parasitol 2000; 111: 153-61.
27. Decuypere S, Elinck E, Van Overmeir C, Talisuna AO, D'Alessandro U, Dujardin JC. Pathogen genotyping in polyclonal infections: application of a fluorogenic polymerase-chain-reaction assay in malaria. J Infect Dis 2003; 188: 1245-9.
28. MacLeod A. Minisatellites and MVR-PCR for the individual identification of parasite isolates. Methods Mol Biol 2004; 270: 187-202.
29. Marks F, Meyer CG, Sievertsen J, Timmann C, Evans J, Horstmann RD, May J. Genotyping of Plasmodium falciparum pyrimethamine resistance by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry. Antimicrob Agents Chemother 2004; 48: 466-72.
30. 19 haplotypes. Am J Trop Med Hyg 2007; 77: 250-5.
31. Jordan S, Jelinek T, Aida AO, Peyerl-Hoffmann G, Heuschkel C, el Valy AO, Christophel EM. Population structure of Plasmodium falciparum isolates during an epidemic in southern Mauritania. Trop Med Int Health 2001; 6: 761-6.
32. Ntoumi F, Rogier C, Dieye A, Trape JF, Millet P, Mercereau-Puijalon O. Imbalanced distribution of Plasmodium falciparum MSP-1 genotypes related to sickle-cell trait. Mol Med 1997; 3: 581-92.
33. Ferreira MU, Liu Q, Kaneko O, Kimura M, Tanabe K, Kimura EA, Katzin AM, Isomura S, Kawamoto F. Allelic diversity at the merozoite surface protein-1 locus of Plasmodium falciparum in clinical isolates from the southwestern Brazilian Amazon. Am J Trop Med Hyg 1998; 59: 474-80.
34. Babiker HA, Ranford-Cartwright LC, Walliker D. Genetic structure and dynamics of Plasmodium falciparum infections in the Kilombero region of Tanzania. Trans R Soc Trop Med Hyg 1999; 93 (Suppl 1): 11-4.
35. Engelbrecht F, Togel E, Beck HP, Enwezor F, Oettli A, Felger I. Analysis of Plasmodium falciparum infections in a village community in Northern Nigeria: determination of MSP-2 genotypes and parasite-specific IgG responses. Acta Trop 2000; 74: 63-71.
36. Ranjit MR, Das A, Das BP, Das BN, Dash BP, Chhotray GP. Distribution of Plasmodium falciparum genotypes in clinically mild and severe malaria cases in Orissa, India. Trans R Soc Trop Med Hyg 2005; 99: 389-95.
37. Biswas S, Escalante A, Chaiyaroj S, Angkasekwinai P, Lal AA. Prevalence of point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from India and Thailand: a molecular epidemiologic study. Trop Med Int Health 2000; 5: 737-43.
38. Snounou G, Beck HP. The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment. Parasitol Today 1998; 14: 462-7.
39. Cattamanchi A, Kyabayinze D, Hubbard A, Rosenthal PJ, Dorsey G. Distinguishing recrudescence from reinfection in a longitudinal anfirnalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp. Am J Trop Med Hyg 2003; 68: 133-9.
40. Greenhouse B, Myrick A, Dokomajilar C, Woo JM, Carlson EJ, Rosenthal PJ, Dorsey G. Validation of microsatellite markers for use in genotyping polyclonal Plasmodium falciparum infections. Am J Trop Med Hyg 2006; 75: 836-42.
41. Farnert A, Snounou G, Rooth I, Bjorkman A. Daily dynamics of Plasmodium falciparum subpopulations in asymptomatic children in a holoendemic area. Am J Trop Med Hyg 1997; 56: 538-47.
42. 19 kDa. Malar J 2006; 5: 31.
43. Jiang G, Daubenberger C, Huber W, Matile H, Tanner M, Pluschke G. Sequence diversity of the merozoite surface protein 1 of Plasmodium falciparum in clinical isolates from the Kilombero district, Tanzania. Acta Trop 2000; 74: 51-61.
44. Konate L, Zwetyenga J, Rogier C, Bischoff E, Fontenille D, Tall A, Spiegel A, Trape JF, Mercereau-Puijalon O. Variation of Plasmodium falciparum MSP-1 block 2 and MSP-2 allele prevalence and of infection complexity in two neighbouring Senegalese villages with different transmission conditions. Trans R Soc Trop Med Hyg 1999; 93 (Suppl 1): 21-8.
45. Cavanagh DR, Elhassan IM, Roper C, Robinson VJ, Giha H, Holder AA, Hviid L, Theander TG, Arnot DE, McBride JS. A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. J Immunol 1998; 161: 347-59.
46. Conway DJ, Roper C, Oduola AM, Arnot DE, Kremsner PG, Grobusch MP, Curtis CF, Greenwood BM. High re-combination rate in natural populations of Plasmodium falciparum. Proc Natl Acad Sci USA 1999; 96: 4506-11.
47. Felger I, Smith T, Edoh D, Kitua. A, Alonso P, Tanner M, Beck HP. Multiple Plasmodium falciparum infections in Tanzanian infants. Trans R Soc Trop Med Hyg 1999; 93 (Suppl 1): 29-34.
48. Issifou S, Rogier C, Adjagba-Olakpo M, Chabi-Worou N, Ntoumi F. Complexity and genetic diversity of Plasmodium falciparum infections in young children living in uban areas of Central and West Africa. Parasitol Res 2003; 90: 423-8.
49. Arnot D. Unstable malaria in Sudan: the influence of the dry season. Clone multiplicity of Plasmodium falciparum infections in individuals exposed to variable levels of disease transmission. Trans R Soc Trop Med Hyg 1998; 92: 580-5.
50. Zwetyenga J, Rogier C, Tall A, Fontenille D, Snounou G, Trape JF, Mercereau-Puijalon O. No influence of age on infection complexity and allelic distribution in Plasmodium falciparum infections in Ndiop, a Senegalese village with seasonal, mesoendemic malaria. Am J Trop Med Hyg 1998; 59: 726-35.
51. Owusu-Agyei S, Smith T, Beck HP, Amenga-Etego L, Felger I. Molecular epidemiology of Plasmodium falciparum infections among asymptomatic inhabitants of a holoendemic malarious area in northern Ghana. Trop Med Int Health 2002; 7: 421-8.
52. Lindblade KA, Walker ED, Onapa AW, Katungu J, Wilson ML, Highland malaria in Uganda: prospective analysis of an epidemic associated with El Nino. Trans R Soc Trop Med Hyg 1999; 93: 480-7.
53. Farnert A, Rooth I, Svensson, Snounou G, Bjorkman A. Complexity of Plasmodium falciparum infections is consistent over time and protects against clinical disease in Tanzanian children. J Infect Dis 1999; 179: 989-95.
54. Sakihama N, Ohmae-H, Bakote'e B, Kawabata M, Hirayama K, Tanabe K. Limited allelic diversity of Plasmodium falciparum merozoite surface protein 1 gene from populations in the Solomon Islands. Am J Trop Med Hyg 2006; 74: 31-40.
55. Raj DK, Das BR, Dash AP, Supakar PC. Genetic diversity in the merozoite surface protein 1 gene of Plasmodium falciparum in different malaria-endemic localities. Am J Trop Med Hyg 2004; 71: 285-9.
56. Talisuna AO, Langi P, Mutabingwa TK, Van Marck E, Speybroeck N, Egwang TG, Watkins WW, Hastings IM, D'Alessandro U. Intensity of transmission and spread of gene mutations linked to chloroquine and sulphadoxine-pyrimethamine resistance in falciparum malaria. Int J Parasitol 2003; 33: 1051-8.
57. Haddad D, Snounou G, Mattei D, Enamorado IG, Figueroa J, Stahl S, Berzins K. Limited genetic diversity of Plasmodium falciparum in field isolates from Honduras. Am J Trop Med Hyg 1999; 60: 30-4.
58. Appawu M, Owusu-Agyei S, Dadzie S, Asoala V, Anto F, Koram K, Rogers W, Nkrumah F, Hoffman SL, Fryauff DJ. Malaria transmission dynamics at a site in northern Ghana proposed for testing malaria vaccines. Trop Med Int Health 2004; 9: 164-70.
59. Sakihama N, Nakamura M, Palanca AA Jr, Argubano RA, Realon EP, Larracas AL, Espina. RL, Tanabe K. Allelic diversity in the merozoite surface protein 1 gene of Plasmodium falciparum on Palawan Island, the Philippines. Parasitol Int 2007; 56: 185-94.
60. Beck HP, Felger I, Huber W, Steiger S, Smith T, Weiss N, Alonso P, Tanner M. Analysis of multiple Plasmodium falciparum infections in Tanzanian children during the phase III trial of the malaria vaccine SPf66. J Infect Dis 1997; 175: 921-6.
61. Al-Yaman F, Genton B, Reeder JC, Anders RF, Smith T, Alpers MP. Reduced risk of clinical malaria in children infected with multiple clones of Plasmodium falciparum in a highly endemic area: a propective community study. Trans R Soc Trop Med Hyg 1997; 91: 602-5.
62. Smith T, Felger I, Kitua A, Tanner M, Beck HP. Dynamics of multiple Plasmodium falciparum infections in infants in a highly endemic area of Tanzania. Trans R Soc Trop Med Hyg 1999; 93 (Suppl 1): 35-9.
63. Smith T, Beck HP, Kitua A, Mwankusye S, Felger I, Fraser-Hurt N, Irion A, Alonso P, Teuscher T, Tanner M. Age dependence of the multiplicity of Plasmodium falciparum infections and of other malariological indices in an area of high endemicity. Trans R Soc Trop Med Hyg 1999; 93 (Suppl 1): 15-20.
64. Ofosu-Okyere A, Mackinnon MJ, Sowa MP, Koram KA, Nkrumah F, Osei YD, Hill WG, Wilson MD, Arnot DE. Novel Plasmodium falciparum clones and rising clone multiplicities are associated with the increase in malaria morbidity in Ghanaian children during the transition into the high transmission season. Parasitology 2001; 123: 113-23.
65. IE AE, Elghazali G, TM AE, Hamad AA, Babiker HA, Elbashir MI, Giha HA. Allelic polymorphism of MSP-2 gene in severe P. falciparum malaria in an area of low and seasonal transmission. Parasitol Res 2007; 102: 29-34.
66. Cortes A, Mellombo M, Benet A, Lorry K, Rare L, Reeder JC. Plasmodium falciparum: distribution of MSP-2 geno-types among symptomatic and asymptomatic individuals from the Wosera region of Papua New Guinea. Exp Parasitol 2004; 106: 22-9.
67. Shigidi MM, Hashim RA, Idris MN, Mukhtar AM, Sokrab TE. Parasite diversity in adult patients with cerebral malaria: a hospital-based, case-control study. Am J Trop Med Hyg 2004; 71: 754-7.
68. IE AE, TM AE, Elghazali G, Elbashir MI, Giha HA. Genetic fingerprints of parasites causing severe malaria in a setting of low transmission in Sudan. J Mol Microbiol Biotechnol 2007; 13: 89-95.
69. Ariey F, Hommel D, Le Scanf C, Duchemin JB, Peneau C, Hulin A, Sarthou JL, Reynes JM, Fandeur T, Mercereau-Puijalon O. Association of severe malaria with a specific Plasmodium falciparum genotype in French Guiana. J Infect Dis 2001; 184: 237-41.
70. Conway DJ, Cavanagh DR, Tanabe K, Roper C, Mikes ZS, Sakihama N, Bojang KA, Oduola AM, Kremsner PG, Arnot DE, Greenwood BM, McBride JS. A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nature Med 2000; 6: 689-92.
71. Lell B, May J, Schmidt-Ott RJ, Lehman LG, Luckner D, Greve B, Matousek P, Schmid D, Herbich K, Mockenhaupt FP, Meyer CG, Bienzle U, Kremsner PG. The role of red blood cell polymorphisms in resistance and susceptibility to malaria. Clin Infect Dis 1999; 28: 794-9.
72. Aidoo M, Terlouw DJ, Kolczak MS, McElroy PD, ter Kuile FO, Kariuki S, Nahlen BL, Lal AA, Udhayakumar V. Protective effects of the sickle-cell gene against malaria morbidity and mortality. Lancet 2002; 359: 1511-2.
73. Ntoumi F, Mercereau-Puijalon O, Ossari S, Luty A, Reltien J, Georges A, Millet P. Plasmodium falciparum: sickle-cell trait is associated with higher prevalence of multiple infections in Gabonese children with asymptomatic infections. Exp Parasitol 1997; 87: 39-46.
74. Williams TN, Mwangi TW, Roberts DJ, Alexander ND, Weatherall DJ, Wambua S, Kortok M, Snow RW, Marsh K. An immune basis for malaria protection by the sickle-cell trait. PLoS Med 2005; 2: e128.
75. Mockenhaupt FP, Ehrhardt S, Otchwemah R, Eggelte TA, Anemana SD, Stark K, Bienzle U, Kohne E. Limited influence of haemoglobin variants on Plasmodium falciparum MSP-1 and MSP-2 alleles in symptomatic malaria. Trans R Soc Trop Med Hyg 2004; 98: 302-10.
76. +-thalassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci USA 1997; 94: 14736-41.
77. Meyer CG, May J, Arez AP, Gil JP, Do Rosario V. Genetic diversity of Plasmodium falciparum: asexual stages. Trop Med Int Health 2002; 7: 395-408.
78. Jelinek T, Kilian AH, Kabagambe G, von Sonnenburg F. Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in Uganda: correlation with polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes. Am J Trop Med Hyg 1999; 61: 463-6.
79. Le Bras J, Durand R. The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum. Fundam Clin Pharmacol 2003; 17: 147-53.
80. Talisuna AO, Langi P, Bakyaita N, Egwang T, Mutabingwa TK, Watkins W, Van Marck E, D'Alessandro U. Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: what is the relationship between these three factors? Trans R Soc Trop Med Hyg 2002; 96: 310-7.
81. Roper C, Pearce R, Bredenkamp B, Gumede J, Drakeley C, Mosha F, Chandramohan D, Sharp B. Antifolate anti-malarial resistance in southeast Africa: a population-based analysis. Lancet 2003; 361: 1174-81.
82. Ranjit MR, Das A, Chhotray GP, Das BP, Das BN, Acharya AS. The PfCRT (K76T) point mutation favours clone multiplicity and disease severity in Plasmodium falciparum infection. Trop Med Int Health 2004; 9: 857-61.
83. Omar SA, Adagu IS, Gump DW, Ndaru NP, Warhurst DC. Plasmodium falciparum in Kenya: high prevalence of drug-resistance-associated polymorphisms in hospital admissions with severe malaria in an epidemic area. Ann Trop Med Parasitol 2001; 95: 661-9.
84. Ekala MT, Jouin H, Lekoulou F, Issifou S, Mercereau-Puijalon O, Ntoumi F. Plasmodium falciparum merozoite surface protein 1 (MSP-1): genotyping and humoral responses to allele-specific variants. Acta Trop 2002; 81: 33-46.
85. Bacarese-Hamilton T, Bistoni F, Crisanti A. Protein microarrays: from serodiagnosis to whole proteome scale analysis of the immune response against pathogenic microorganisms. Biotechniques 2002 December; (Suppl): 24-9.